Northeast Pharmaceutical announced that director Guo Jianmin, who holds 3.195,000 shares of the company and accounts for 0.2239% of the total share capital, plans to reduce his holdings by no more than 798,800 shares through centralized bidding within 3 months after 15 trading days from the date of disclosure of the announcement on September 2, 2026, accounting for 0.0560% of the total share capital.

Northeast Pharmaceutical announced that director Guo Jianmin, who holds 3.195,000 shares of the company and accounts for 0.2239% of the total share capital, plans to reduce his holdings by no more than 798,800 shares through centralized bidding within 3 months after 15 trading days from the date of disclosure of the announcement on September 2, 2026, accounting for 0.0560% of the total share capital.